(VIANEWS) – Badger Meter (BMI), Profire Energy (PFIE), Incyte Corporation (INCY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Badger Meter (BMI)
19.8% sales growth and 17.35% return on equity
Badger Meter, Inc. manufactures and markets flow measurement, quality, control, and communication solutions in the United States, Asia, Canada, Europe, Mexico, the Middle East, and internationally. It offers mechanical or static water meters, and related radio and software technologies and services to municipal water utilities. The company also provides flow instrumentation products, including meters, valves, and other sensing instruments to measure and control fluids going through a pipe or pipeline, including water, air, steam, oil, and other liquids and gases to original equipment manufacturers as the primary flow measurement device within a product or system, as well as through manufacturers' representatives. Its flow instrumentation products are used in water/wastewater, heating, ventilating and air conditioning, and corporate sustainability markets. In addition, the company offers ORION Migratable for automatic meter reading; ORION (SE) for traditional fixed network applications; and ORION Cellular for infrastructure-free fixed network meter reading solution, as well as BEACON advanced metering analytics, a secure cloud-hosted software suite that establishes alerts for specific conditions and allows consumer engagement tools that permit end water customers to view and manage their water usage activity. It also serves water utilities, industrial, and other industries. The company sells its products directly, as well as through resellers and representatives. Badger Meter, Inc. was founded in 1905 and is headquartered in Milwaukee, Wisconsin.
Earnings Per Share
As for profitability, Badger Meter has a trailing twelve months EPS of $2.42.
PE Ratio
Badger Meter has a trailing twelve months price to earnings ratio of 69.07. Meaning, the purchaser of the share is investing $69.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.35%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Badger Meter’s EBITDA is 7.6.
Moving Average
Badger Meter’s worth is higher than its 50-day moving average of $153.23 and way higher than its 200-day moving average of $128.58.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 24, 2023, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 0.55%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 32.8% and 30%, respectively.
Previous days news about Badger Meter(BMI)
- According to Zacks on Friday, 18 August, "Some better-ranked stocks worth consideration in the broader technology space are Badger Meter (BMI Quick QuoteBMI – Free Report) , Salesforce (CRM Quick QuoteCRM – Free Report) and Pegasystems (PEGA Quick QuotePEGA – Free Report) . "
- According to Zacks on Friday, 18 August, "Some better-ranked stocks in the broader technology sector are Badger Meter (BMI Quick QuoteBMI – Free Report) , Arista Networks (ANET Quick QuoteANET – Free Report) and Salesforce (CRM Quick QuoteCRM – Free Report) . ", "While Badger Meter sports a Zacks Rank #1 (Strong Buy), Arista Networks and Salesforce each carry a Zacks Rank #2 (Buy). "
- According to Zacks on Friday, 18 August, "Some other top-ranked stocks in the broader technology space are Woodward (WWD Quick QuoteWWD – Free Report) , Aspen Technology (AZPN Quick QuoteAZPN – Free Report) and Badger Meter (BMI Quick QuoteBMI – Free Report) . ", "Woodward and Badger Meter presently sport a Zacks Rank #1 (Strong Buy), whereas Aspen Technology currently carries a Zacks Rank #2. "
2. Profire Energy (PFIE)
13.2% sales growth and 12.59% return on equity
Profire Energy, Inc., a technology company, provides burner, and combustion management systems and solutions for natural and forced draft applications in the United States and Canada. It primarily focuses on the upstream, midstream, and downstream transmission segments of the oil and gas industry. It also sells and installs its systems in Europe, South America, Africa, the Middle East, and Asia. The company was founded in 2002 and is based in Lindon, Utah.
Earnings Per Share
As for profitability, Profire Energy has a trailing twelve months EPS of $0.12.
PE Ratio
Profire Energy has a trailing twelve months price to earnings ratio of 11.83. Meaning, the purchaser of the share is investing $11.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.59%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 200% and 50%, respectively.
3. Incyte Corporation (INCY)
9.3% sales growth and 8.31% return on equity
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults with intermediate or high-risk myelofibrosis; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include axatilimab, an anti-CSF-1R monoclonal antibody being developed as a therapy for patients with chronic GVHD as well as in additional immune-mediated diseases; and parsaclisib, a PI3Kd inhibitor which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It also develops retifanlimab, is in Phase III clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer, and Fast Track designation for the treatment of metastatic MSI-H or DNA mismatch repair (dMMR) endometrial cancer; and INCB99280 and INCB99318 currently under Phase I for the treatment solid tumors. It has collaboration out- license agreements with Novartis, Lilly, Innovent, InnoCare, Maruho, and CMS Aesthetics Limited; and in- license agreements with Agenus, Merus, MacroGenics, Syros, MorphoSys, and Syndax. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Earnings Per Share
As for profitability, Incyte Corporation has a trailing twelve months EPS of $1.43.
PE Ratio
Incyte Corporation has a trailing twelve months price to earnings ratio of 46.03. Meaning, the purchaser of the share is investing $46.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.31%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Incyte Corporation’s EBITDA is 3.12.
Moving Average
Incyte Corporation’s value is above its 50-day moving average of $63.08 and under its 200-day moving average of $72.50.
4. FirstService Corporation (FSV)
5.9% sales growth and 14.19% return on equity
FirstService Corporation, together with its subsidiaries, provides residential property management and other essential property services to residential and commercial customers in the United States and Canada. The company operates in two segments, FirstService Residential and FirstService Brands. The FirstService Residential segment offers property management services for private residential communities, such as condominiums, co-operatives, homeowner associations, master-planned communities, active adult and lifestyle communities, and various other residential developments. This segment also provides a range of ancillary services, including on-site staffing for building engineering and maintenance, full-service swimming pool and amenity management, and security and concierge/front desk; and financial services comprising cash management, other banking transaction-related, and specialized property insurance brokerage. In addition, this segment offers energy management solutions and advisory services, and resale processing services. The FirstService Brands segment provides property services through 5 franchise networks; and company-owned locations, including 19 California Closets and 11 Paul Davis Restoration locations. It provides residential and commercial restoration, painting, and floor coverings design and installation services; custom-designed and installed closet, and home storage solutions; home inspection services; and fire protection and related services. This segment offers its services primarily under the Paul Davis Restoration, Interstate Restoration, FirstOnSite Restoration, Century Fire Protection, CertaPro Painters, California Closets, Pillar to Post Home Inspectors, and Floor Coverings International brand names. FirstService Corporation was founded in 1989 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, FirstService Corporation has a trailing twelve months EPS of $2.76.
PE Ratio
FirstService Corporation has a trailing twelve months price to earnings ratio of 56.16. Meaning, the purchaser of the share is investing $56.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.19%.
